These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9798025)

  • 1. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S; Schreurs A; Siami G; Barkman HW; Anzueto A; Shan M; Moesker H; Stack T; Kowalsky S
    Clin Infect Dis; 1998 Oct; 27(4):730-8. PubMed ID: 9798025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S; McCarty J; Farkas S; Drehobl M; Tosiello R; Shan M; Aneiro L; Kowalsky S
    Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group.
    Anzueto A; Niederman MS; Haverstock DC; Tillotson GS
    Clin Ther; 1997; 19(5):989-1001. PubMed ID: 9385486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
    Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
    Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S; DeAbate CA; Haverstock D; Aneiro L; Church D
    Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE; Zuck P; Vogel F; McIvor A; Peirzchala W; Smakal M; Staley H; Marr C
    J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
    Wilson R; Schentag JJ; Ball P; Mandell L;
    Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
    Anzueto A; Niederman MS; Tillotson GS
    Clin Ther; 1998; 20(5):885-900. PubMed ID: 9829441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
    Chodosh S; Lakshminarayan S; Swarz H; Breisch S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Busman TA; Norris S; Notario GF
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Weiss LR
    Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
    Clifford K; Huck W; Shan M; Tosiello R; Echols RM; Heyd A
    Ann Otol Rhinol Laryngol; 1999 Apr; 108(4):360-7. PubMed ID: 10214783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis.
    Wilson R; Kubin R; Ballin I; Deppermann KM; Bassaris HP; Leophonte P; Schreurs AJ; Torres A; Sommerauer B
    J Antimicrob Chemother; 1999 Oct; 44(4):501-13. PubMed ID: 10588312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables.
    Tran JQ; Ballow CH; Forrest A; Hyatt JM; Sands MF; Peloquin CA; Schentag JJ
    J Antimicrob Chemother; 2000 Mar; 45():9-17. PubMed ID: 10719007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
    Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
    Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia.
    Pryka R; Kowalsky S; Haverstock D
    Clin Ther; 1998; 20(1):141-55. PubMed ID: 9522111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE; Cranfield R; Breisch S; Pettit R
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis.
    Adler JL; Jannetti W; Schneider D; Zhang J; Palmer R; Notario G
    Clin Ther; 2000 Dec; 22(12):1410-20. PubMed ID: 11192133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.